Sousa N, Geiss C, Bindila L, Lieberwirth I, et al. Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. BMC Cancer 2023;23:762.
PMID: 37587449